Lahore, Pakistan

Javed Akram

This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 2012-2014.


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal2 out of 834,411 
Other
 patents

Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Javed Akram: Innovator in Antiviral Research

Introduction

Javed Akram is a notable inventor based in Lahore, Pakistan. He has made significant contributions to the field of antiviral research, holding 2 patents that focus on innovative compounds for treating viral infections. His work is characterized by a commitment to developing effective antiviral agents.

Latest Patents

One of Javed Akram's latest patents is for 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections. This compound has demonstrated surprising antiviral activity, particularly when used in combination with other antiviral agents such as interferon and/or ribavirin. Another significant patent is for 7-nitro-2-(3-nitro phenyl)-4H-3,1-benzoxazin-4-one or derivatives thereof, which also shows promising antiviral activity in similar combinations.

Career Highlights

Throughout his career, Javed Akram has focused on the development of antiviral therapies. His innovative approach has led to the creation of compounds that have the potential to significantly impact the treatment of viral infections. His research is recognized for its scientific rigor and practical applications in medicine.

Collaborations

Javed Akram has collaborated with notable colleagues, including Usman Ashfaq and Khalid Mohammed Khan. These partnerships have enhanced his research efforts and contributed to the advancement of antiviral therapies.

Conclusion

Javed Akram stands out as an influential inventor in the field of antiviral research. His patents reflect a dedication to improving treatment options for viral infections, showcasing his innovative spirit and commitment to scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…